This Perspective discusses current evidence on clonal hematopoiesis dynamics in humans and compares mathematical models used to predict CH progression, highlighting their implications for the clinical management of individuals with precursor states.
- Sadegh Marzban
- Thomas Stiehl
- Jeffrey West